Amyotrophic lateral sclerosis , also known as Lou Gehrig’s disease, is a fatal neurodegenerative disorder that is characterized by the selective loss of motor neurons in the spinal cord, brain stem, and motor cortex. An estimated 30,000 Americans are living with ALS, which often arises spontaneously and afflicts otherwise healthy adults. More than half of Amyotrophic Lateral Sclerosis patients die within 2.5 years following the onset of symptoms.
At present, there is an absence of clinical trials investigating the use of cannabinoids as a disease-modifying therapy for Amyotrophic Lateral Sclerosis. However, preclinical models indicate that cannabinoids may hold the potential to delay Amyotrophic Lateral Sclerosis progression, lending support to anecdotal reports by some patients that cannabinoids may be efficacious in moderating the disease’s development and in alleviating certain ALS-related symptoms such as pain, appetite loss, spasticity, depression and drooling
Amyotrophic Lateral Sclerosis ALS Marijuana Video Testimonials